MarketPeel
Insider Trading Intelligence
RG

Robert E. George

MBRX
DIRECTOR · MOLECULIN BIOTECH, INC. · CIK 0001674701
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$10.0K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
165,336
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert E. George, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+42.63%-0.63%+43.26%+43.26%
14d1+100.00%+11.13%-0.37%+11.50%+11.50%
30d1+0.00%-24.76%+2.60%-27.36%-27.36%
60d1+0.00%-16.68%+6.77%-23.45%-23.45%
90d1+0.00%-45.98%+9.62%-55.59%-55.59%
180d1+0.00%-62.85%+14.83%-77.68%-77.68%
1y1+0.00%-81.27%+28.04%-109.31%-109.31%
2y1+0.00%-98.39%+47.45%-145.84%-145.84%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MBRX · 165,336 shares · as of Nov 12, 2025
041,33482,668124,002165,33620212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 8 buys / 0 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
150,000165,336Nov 12, 2025Nov 14, 2025View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
10,00015,336Nov 4, 2024Nov 6, 2024View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASE
14,493$0.69$10.0K14,660Dec 26, 2023Dec 27, 2023View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
15,00080,001May 25, 2023May 26, 2023View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
23,33350,001Jun 20, 2022Jun 22, 2022View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
15,00065,001Jun 20, 2022Jun 22, 2022View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
10,00026,668Jun 7, 2021Jun 9, 2021View →
MBRX
MOLECULIN BIOTECH, INC.
PURCHASEGRANT
Stock grant
15,000100,000Jun 15, 2020Jun 16, 2020View →
Other insiders · MBRX
Loading peer insiders…
About this filer
CIK 0001674701
ROLE
Director
PRIMARY
MBRX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001674701DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback